Tafamidis improves myocardial longitudinal strain in A97S transthyretin cardiac amyloidosis

Tafamidis improves myocardial longitudinal strain in A97S transthyretin cardiac amyloidosis

Background: Transthyretin cardiomyopathy (ATTR-CM) is a debilitating disease that has received much attention since the emergence of novel treatments. The Transthyretin Cardiomyopathy Clinical Trial showed that tafamidis, a transthyretin tetramer stabilizer, effectively reduced the declines in funct...

Full description

Bibliographic Details
Main Authors: Yuan-Kun (Aden) Wu, An-Li Yu, Mei-Fang Cheng, Lung-Chun Lin, Ming-Jen Lee, Chia-Hung Chou, Chia-Tung Shun, Hsueh-Wen Hsueh, Jimmy Jyh-Ming Juang, Ping-Huei Tseng, Siao-Ping Lin, Mao-Yuan Su, Chi-Chao Chao, Sung-Tsang Hsieh, Cheng-Hsuan Tsai, Yen-Hung Lin
Format: Article
Language:English
Published: SAGE Publishing 2024-01-01
Series:Therapeutic Advances in Chronic Disease
Online Access:https://doi.org/10.1177/20406223231222828

Internet

https://doi.org/10.1177/20406223231222828

Similar Items